S Bank Fund Management Ltd Invests $340,000 in Keurig Dr Pepper, Inc (NASDAQ:KDP)

S Bank Fund Management Ltd purchased a new stake in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 9,924 shares of the company’s stock, valued at approximately $340,000.

Several other large investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in Keurig Dr Pepper by 21.3% in the first quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company’s stock worth $4,962,338,000 after acquiring an additional 25,425,644 shares during the period. JPMorgan Chase & Co. grew its stake in Keurig Dr Pepper by 108.1% during the first quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company’s stock valued at $1,330,565,000 after acquiring an additional 20,196,835 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Keurig Dr Pepper by 36.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock valued at $1,755,564,000 after acquiring an additional 14,473,054 shares in the last quarter. Northern Trust Corp grew its stake in Keurig Dr Pepper by 20.6% in the 4th quarter. Northern Trust Corp now owns 13,598,633 shares of the company’s stock worth $436,788,000 after buying an additional 2,320,614 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Keurig Dr Pepper by 18.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 9,926,645 shares of the company’s stock worth $318,836,000 after buying an additional 1,548,622 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.

Keurig Dr Pepper Trading Up 0.0%

Shares of KDP stock opened at $34.82 on Thursday. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.64 and a quick ratio of 0.40. The company has a market cap of $47.30 billion, a price-to-earnings ratio of 31.09, a PEG ratio of 2.54 and a beta of 0.45. The stock has a 50 day simple moving average of $33.42 and a 200-day simple moving average of $33.49. Keurig Dr Pepper, Inc has a 1-year low of $30.12 and a 1-year high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP) last announced its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%. The business had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. During the same period in the prior year, the company posted $0.45 EPS. The business’s quarterly revenue was up 6.1% on a year-over-year basis. On average, equities research analysts expect that Keurig Dr Pepper, Inc will post 1.92 EPS for the current fiscal year.

Keurig Dr Pepper Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.23 dividend. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.6%. Keurig Dr Pepper’s dividend payout ratio is currently 82.14%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, July 17th. Hsbc Global Res upgraded shares of Keurig Dr Pepper from a “hold” rating to a “strong-buy” rating in a report on Friday, April 25th. UBS Group reduced their target price on shares of Keurig Dr Pepper from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Thursday, July 17th. HSBC raised shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating and upped their target price for the stock from $36.00 to $42.00 in a research report on Friday, April 25th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $42.00 price objective on shares of Keurig Dr Pepper in a research report on Tuesday, April 22nd. Two investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Keurig Dr Pepper has a consensus rating of “Moderate Buy” and a consensus price target of $39.77.

Insider Activity at Keurig Dr Pepper

In other Keurig Dr Pepper news, Director Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares of the company’s stock, valued at $75,412,360.10. The trade was a 8.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares of the company’s stock, valued at approximately $2,777,320.26. This represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 672,000 shares of company stock valued at $22,235,760. 0.40% of the stock is owned by company insiders.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.